RecruitingNot Applicable

Nutritional Therapy Enriched With Omega-3 in Patients With Lung Resection

Mexico310 participantsStarted 2024-07-25

Plain-language summary

The aim of this study is to analyze the effect of enriched formula with omega-3 in the 30-day incidence infection and inflammatory response following lung resection surgery in lung cancer patients.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Lung cancer diagnosis * Elective surgery for lung resection schedule at least four days before surgery * Signed informed consent. Exclusion Criteria: * Acute or chronic organ failure as hepatic or renal insufficiency * Patients with fish-allergy * History of any surgery within 3 months * Immunocompromised patients

What they're measuring

30-day incidence infection

Timeframe: 30-day incidence infection following lung resection in lung cancer patients.

Trial details

NCT IDNCT06531460

SponsorNational Institute of Respiratory Diseases, Mexico

Sponsor typeOTHER_GOV

Study typeINTERVENTIONAL

Primary completion2026-12

Contact for this trial

Ivan A Osuna-Padilla, PhD

5487-1700 ivan.osuna@iner.gob.mx

View on ClinicalTrials.gov More Lung Cancer trials